Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

PharmaPrint begins phase II trial of herbal treatment for BPH

Sep. 11, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

Agents useful for BPH from Pfizer

Sep. 9, 1997

Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040

Sep. 9, 1997

Uroselective alpha1-adrenoceptor antagonists for BPH

Sep. 8, 1997

Antioxidant from Otsuka effective in animal model of nephritis

Sep. 5, 1997

New aldosterone antagonists from Yamanouchi

Aug. 26, 1997

ETA/ETB antagonist protects against renal insufficiency in canine model

Aug. 19, 1997

Clinical trial results announced for novel incontinence therapeutic

Aug. 18, 1997

Vasopressin agonist from Otsuka

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...